Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13006675 | 0.98 | USP2 (0.38) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL9913180 | 0.91 | USP2 (0.41) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL13006674 | 0.89 | USP2 (0.38) | USP2PLA2G2C | |
| SCHEMBL35419 | 0.89 | USP2 (0.34) | USP2KDM4EMEN1KMT2A | |
| SCHEMBL13006671 | 0.88 | USP2 (0.43) | USP2KDM4EDUSP3MEN1KMT2A | |
| SCHEMBL20437548 | 0.88 | USP2 (0.46) | USP2 | |
| SCHEMBL11925337 | 0.88 | USP2 (0.46) | USP2 | |
| SCHEMBL20437550 | 0.86 | USP2 (0.47) | USP2PLA2G2C | |
| SCHEMBL27273268 | 0.85 | USP2 (0.44) | USP2 | |
| SCHEMBL27273267 | 0.85 | USP2 (0.44) | USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8198473-B2 | Process for preparing organically modified siloxanes | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-06-12 | — | — | US | disclosed |
| US-20100056818-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | EVONIK GOLDSCHMIDT GMBH (DE) | 2010-03-04 | — | — | US | disclosed |
| US-7635581-B2 | Process for preparing organically modified siloxanes | GOLDSCHMIDT GMBH (DE) | 2009-12-22 | — | — | US | disclosed |
| US-20070184006-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | GOLDSCHMIDT GMBH (DE) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070184006-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | HSD17B12, CYP51A1, ESD | USP2 497/4885KDM4E 563/4885DUSP3 4483/4885 |
| US-20100056818-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | HSD17B12, CYP51A1, ESD | USP2 497/4885KDM4E 563/4885DUSP3 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.